Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02566902 · ClinicalTrials.gov registry record · NA

Comparison of Breath-Enhanced and T-Piece Nebulizers in Children With Acute Asthma

A NA study of Asthma, sponsored by Seton Healthcare Family.

Completed
Registry status
NA
Development phase
118
Enrollment target
1
Study location

NCT02566902 is a NA study of Asthma that has completed, run by Seton Healthcare Family. The registered enrollment target is 118 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02566902, a NA study of Asthma, has completed, sponsored by Seton Healthcare Family.

COMPLETED
Registry status
NA
Development phase
118 participants
Enrollment target
1
Study location

Study Summary

This is a blinded observer randomized controlled trial comparing two nebulizer devices. The objective of this study is to evaluate the efficacy of two different nebulizers.

Conditions Studied

Interventions

  • DRUG Albuterol
  • DEVICE T-Piece Nebulizer
  • DEVICE Breath-Enhanced Nebulizer
  • PROCEDURE Pre-Treatment Spirometry Measurement
  • PROCEDURE Post-Treatment Spirometry Measurement

Study Locations (1)

Texas

  • Dell Children's Medical Center, Emergency Department - Austin

Trial Details

FieldValue
Enrollment Target 118 participants
Start Date 2015-10
Est. Completion 2017-06-30
Phase NA

Sponsor

Seton Healthcare Family

15 total trials

What the Registry Record Tells You About NCT02566902

The ClinicalTrials.gov registry entry for NCT02566902 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (92% lower). The listed sponsor is Seton Healthcare Family, which has 15 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 5 interventions - of which Albuterol is the first listed.

NCT02566902 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02566902 about?

NCT02566902 is a clinical study titled "Comparison of Breath-Enhanced and T-Piece Nebulizers in Children With Acute Asthma". This is a blinded observer randomized controlled trial comparing two nebulizer devices. The objective of this study is to evaluate the efficacy of two different nebulizers.

What is the current status of trial NCT02566902?

This trial is currently completed. It is a NA study. The enrollment target is 118 participants. The study started on 2015-10. Estimated completion is 2017-06-30.

What conditions does trial NCT02566902 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT02566902?

The interventions under investigation include: Albuterol (DRUG), T-Piece Nebulizer (DEVICE), Breath-Enhanced Nebulizer (DEVICE), Pre-Treatment Spirometry Measurement (PROCEDURE), Post-Treatment Spirometry Measurement (PROCEDURE).

Who is sponsoring clinical trial NCT02566902?

This trial is sponsored by Seton Healthcare Family, which has 15 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02566902 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.